The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Randomized, Multicenter Trial of Fluorouracil Plus Leucovorin Administered Either Via Hepatic Arterial or Intravenous Infusion Versus Fluorodeoxyuridine Administered Via Hepatic Arterial Infusion in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
Abstract
PURPOSE: To assess the efficacy and tolerability of three treatments for patients with documented adenocarcinoma of the colon and/or rectum who have undergone complete resection of primary tumor and have nonresectable liver metastases that do not exceed 75% of the liver volume. PATIENTS AND METHODS: A total of 168 patients at 25 treatment centers were enrolled onto this prospective, multicenter, randomized study. The three treatment arms were as follows: (1) fluorouracil (5-FU)/leucovorin (LV) administered via hepatic arterial infusion (HAI), (2) 5-FU/LV administered via intravenous (IV) infusion, and (3) fluorodeoxyuridine (FUDR) administered via HAI. RESULTS: Median times to disease progression for the three treatment arms were as follows: 9.2 months for patients treated with HAI 5-FU/LV, 6.6 months for IV 5-FU/LV, and 5.9 months for HAI FUDR. Median survival times for patients treated with HAI 5-FU/LV, IV 5-FU/LV, and HAI FUDR were 18.7 months, 17.6 months, and 12.7 months, respectively. There was a nearly two-fold increase in time to progression in addition to a survival benefit among patients with an intrahepatic tumor burden of less than 25% who were treated with HAI 5-FU/LV. The most common adverse events were stomatitis, nausea and vomiting, skin irritation, diarrhea, and elevated serum levels of liver enzymes. Some patients exhibited severe reactions, including biliary sclerosis and chemical hepatitis. CONCLUSION: Although the use of HAI 5-FU/LV as a means of treating liver metastases after resection of colorectal carcinoma warrants further investigation, it cannot be recommended as a routine therapeutic measure at this time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Resection of colorectal liver metastases
Scheele, J., Stang, R., Altendorf‐Hofmann, A., & Paul, M. (1995) · World Journal of Surgery · doi:10.1007/bf00316981 · Cited by 1,539
de Gramont, A., Bosset, J. F., Milan, C., Rougier, P., Bouché, O., Etienne, P. L., Morvan, F., Louvet, C., Guillot, T., François, E., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.808 · Cited by 908
Silverberg, E., Boring, C. C., & Squires, T. S. (1990) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.40.1.9 · Cited by 816
Factors influencing the natural history of colorectal liver metastases
Stangl, R., Altendorf-Hofmann, A., Charnley, R. M., & Scheele, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92529-1 · Cited by 722
Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies
Weiss, L., Grundmann, E., Torhorst, J., Hartveit, F., Moberg, I., Eder, M., Fenoglio‐Preiser, C. M., Napier, J., Horne, C. H. W., Lopez, M. J., et al. (1986) · The Journal of Pathology · doi:10.1002/path.1711500308 · Cited by 655
KEMENY, N., DALY, J., REICHMAN, B., GELLER, N., BOTET, J., & ODERMAN, P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-459 · Cited by 649
Rougier, P., Laplanche, A., Huguier, M., Hay, J. M., Ollivier, J. M., Escat, J., Salmon, R., Julien, M., Roullet Audy, J. C., & Gallot, D. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1112 · Cited by 570
Allen-Mersh, T. G., Earlam, S., Fordy, C., Abrams, K., & Houghton, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90750-1 · Cited by 534
Ensminger, W. D., Rosowsky, A., Raso, V., Levin, D. C., Glodé, M., Come, S. E., Steele, G. D., & Frei, E. (1978) · PubMed · Cited by 521
Pharmacologic rationale for regional drug delivery.
Collins, J. M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.498 · Cited by 464
Meta-Analysis Group In Cancer (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.252 · Cited by 441
Martin, J. K. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410200086013 · Cited by 375
Schoenfeld, D. A., & Richter, J. R. (1982) · Biometrics · doi:10.2307/2530299 · Cited by 354
Designs for group sequential tests
Fleming, T. R., Harrington, D. P., & O'Brien, P. C. (1984) · Controlled Clinical Trials · doi:10.1016/s0197-2456(84)80014-8 · Cited by 353
Rougier, P., Milan, C., Lazorthes, F., Fourtanier, G., Partensky, C., Baumel, H., & Faivre, J. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800821034 · Cited by 185
Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR
KEMENY, M. M., BATTIFORA, H., BLAYNEY, D. W., CECCHI, G., GOLDBERG, D. A., LEONG, L. A., MARGOLIN, K. A., & TERZ, J. J. (1985) · Annals of Surgery · doi:10.1097/00000658-198508000-00007 · Cited by 159
Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump
Buchwald, H., Grage, T. B., Vassilopoulos, P. P., Rohde, T. D., Varco, R. L., & Blackshear, P. J. (1980) · Cancer · doi:10.1002/1097-0142(19800301)45:5<866::aid-cncr2820450507>3.0.co;2-3 · Cited by 154
O'Connell, M. J., Nagorney, D. M., Bernath, A. M., Schroeder, G. S., Fitzgibbons, R. J., Mailliard, J. A., Burch, P. A., Bolton, J. S., Colón‐Otero, G., & Krook, J. E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2528 · Cited by 63
Morphological changes after intra-arterial chemotherapy of the liver.
Herrmann, G., Lorenz, M., Kirkowa-Reimann, M., Hottenrott, C., & Hübner, K. (1987) · PubMed · Cited by 33
Self-citationBurke, D., Fordy, C., Earlam, S., & Allen-Mersh, T. G. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.207 · Cited by 10
Cited by
Taylor, A., Primrose, Langeberg, W., Kelsh, Mowat, F., Alexander, D., Choti, M., Poston, G., & Kanas, G. (2012) · Clinical Epidemiology · doi:10.2147/clep.s34285 · Cited by 657
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
Van Cutsem, E., Nordlinger, B., Adam, R., Köhne, C.-H., Pozzo, C., Poston, G., Ychou, M., & Rougier, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.04.012 · Cited by 587
Portier, G., Elias, D., Bouche, O., Rougier, P., Bosset, J.-F., Saric, J., Belghiti, J., Piedbois, P., Guimbaud, R., Nordlinger, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8353 · Cited by 579
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
Zorzi, D., Laurent, A., Pawlik, T. M., Lauwers, G. Y., Vauthey, J.-N., & Abdalla, E. K. (2007) · British Journal of Surgery · doi:10.1002/bjs.5719 · Cited by 532
Kemeny, N. E., Niedzwiecki, D., Hollis, D. R., Lenz, H.-J., Warren, R. S., Naughton, M. J., Weeks, J. C., Sigurdson, E. R., Herndon, J. E., Zhang, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8166 · Cited by 417
Metadata
- Authors
- Lorenz, M., Müller, H.-H., & for the German Cooperative Group on Liver Metastases
- Venue
- Journal of Clinical Oncology
- Published
- 2000-01-01
- Volume
- 18
- Issue
- 2
- Pages
- 243-243
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1961040537
- Cited by
- 308
- References
- 22
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.